BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 19804366)

  • 1. Identification of Factor XIII β-Sandwich Residues Mediating Glutamine Substrate Binding and Activation Peptide Cleavage.
    Mohammed RDS; Piell KM; Maurer MC
    Thromb Haemost; 2024 May; 124(5):408-422. PubMed ID: 38040030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation.
    Hess K; Ajjan R; Phoenix F; Dobó J; Gál P; Schroeder V
    PLoS One; 2012; 7(4):e35690. PubMed ID: 22536427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Structure of Blood Coagulation Factor XIII Is Adapted to Oxidation.
    Vasilyeva A; Yurina L; Shchegolikhin A; Indeykina M; Bugrova A; Kononikhin A; Nikolaev E; Rosenfeld M
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32560304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fbg αC 389-402 Enhances Factor XIII Cross-Linking in the Fibrinogen αC Region Via Electrostatic and Hydrophobic Interactions.
    Ablan FDO; Maurer MC
    Biochemistry; 2023 Jul; 62(14):2170-2181. PubMed ID: 37410946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Based Design of FXIIIa-Blockers: Addressing a Transient Hydrophobic Pocket in the Active Site of FXIIIa.
    Stieler M; Büchold C; Schmitt M; Heine A; Hils M; Pasternack R; Klebe G
    ChemMedChem; 2020 May; 15(10):900-905. PubMed ID: 32181986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coevolution of the coagulation and immune systems.
    Arneth B
    Inflamm Res; 2019 Feb; 68(2):117-123. PubMed ID: 30604212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
    Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC
    Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?
    Korte W
    J Blood Med; 2014; 5():107-13. PubMed ID: 25031548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in the management of congenital Factor XIII deficiency.
    Fadoo Z; Merchant Q; Rehman KA
    J Blood Med; 2013; 4():65-73. PubMed ID: 23761984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections.
    McAdow M; Missiakas DM; Schneewind O
    J Innate Immun; 2012; 4(2):141-8. PubMed ID: 22222316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of introducing fibrinogen Aalpha character into the factor XIII activation peptide segment.
    Jadhav MA; Isetti G; Trumbo TA; Maurer MC
    Biochemistry; 2010 Apr; 49(13):2918-24. PubMed ID: 20218626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Employing mutants to study thrombin residues responsible for factor XIII activation peptide recognition: a kinetic study.
    Isetti G; Maurer MC
    Biochemistry; 2007 Mar; 46(9):2444-52. PubMed ID: 17286389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing thrombin's ability to accommodate a V34F substitution within the factor XIII activation peptide segment (28-41).
    Isetti G; Maurer MC
    J Pept Res; 2004 Mar; 63(3):241-52. PubMed ID: 15049836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function.
    Muszbek L; Adány R; Mikkola H
    Crit Rev Clin Lab Sci; 1996; 33(5):357-421. PubMed ID: 8922891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XIII and venous thromboembolism.
    Bereczky Z; Muszbek L
    Semin Thromb Hemost; 2011 Apr; 37(3):305-14. PubMed ID: 21455864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation factor XIII variants with altered thrombin activation rates.
    Andersen MD; Kjalke M; Bang S; Lautrup-Larsen I; Becker P; Andersen AS; Olsen OH; Stennicke HR
    Biol Chem; 2009 Dec; 390(12):1279-83. PubMed ID: 19804366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
    Bagoly Z; Fazakas F; Komáromi I; Haramura G; Tóth E; Muszbek L
    Thromb Haemost; 2008 Apr; 99(4):668-74. PubMed ID: 18392324
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.